Literature DB >> 35393864

Practical issues in operationalizing the design and outcome evaluation of cluster randomized trials.

Deborah Donnell1.   

Abstract

Trial designs using cluster-level randomization are necessary when interventions have intended effects that cannot be measured with individual randomization. When an intervention is intrinsically only able to be delivered to a cluster or when implementation of an individual level intervention is only feasibly implemented at a cluster level, cluster-level randomization is required. In designing the strategy for evaluation of the primary outcome of a cluster randomized trial, there are a multitude of important decisions to consider. While these decisions are guided primarily by the intervention-who benefits, what is the intended effect and when will it be achieved-there are important detailed choices that affect potential bias and statistical power, and implementation considerations that require compromise for considerations of feasibility and practicality. Through the lens of three large completed cluster randomized trials in HIV prevention, we present specific choices made for the overall evaluation plan, together with some of the detailed considerations, compromises and modifications that occurred during trial implementation.

Entities:  

Keywords:  Cluster randomized trials; HIV prevention; Hawthorne; outcome evaluation

Mesh:

Year:  2022        PMID: 35393864      PMCID: PMC9378425          DOI: 10.1177/17407745221087465

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.599


  13 in total

1.  Transportability of Trial Results Using Inverse Odds of Sampling Weights.

Authors:  Daniel Westreich; Jessie K Edwards; Catherine R Lesko; Elizabeth Stuart; Stephen R Cole
Journal:  Am J Epidemiol       Date:  2017-10-15       Impact factor: 4.897

2.  Effect of community-based voluntary counselling and testing on HIV incidence and social and behavioural outcomes (NIMH Project Accept; HPTN 043): a cluster-randomised trial.

Authors:  Thomas J Coates; Michal Kulich; David D Celentano; Carla E Zelaya; Suwat Chariyalertsak; Alfred Chingono; Glenda Gray; Jessie K K Mbwambo; Stephen F Morin; Linda Richter; Michael Sweat; Heidi van Rooyen; Nuala McGrath; Agnès Fiamma; Oliver Laeyendecker; Estelle Piwowar-Manning; Greg Szekeres; Deborah Donnell; Susan H Eshleman
Journal:  Lancet Glob Health       Date:  2014-04-08       Impact factor: 26.763

3.  The status of the National HIV Surveillance System, United States, 2013.

Authors:  Stacy M Cohen; Kristen Mahle Gray; M Cheryl Bañez Ocfemia; Anna Satcher Johnson; H Irene Hall
Journal:  Public Health Rep       Date:  2014 Jul-Aug       Impact factor: 2.792

4.  Community-based intervention to increase HIV testing and case detection in people aged 16-32 years in Tanzania, Zimbabwe, and Thailand (NIMH Project Accept, HPTN 043): a randomised study.

Authors:  Michael Sweat; Stephen Morin; David Celentano; Marta Mulawa; Basant Singh; Jessie Mbwambo; Surinda Kawichai; Alfred Chingono; Gertrude Khumalo-Sakutukwa; Glenda Gray; Linda Richter; Michal Kulich; Andrew Sadowski; Thomas Coates
Journal:  Lancet Infect Dis       Date:  2011-05-03       Impact factor: 25.071

5.  USING PARTICIPATORY METHODS AND GEOGRAPHIC INFORMATION SYSTEMS (GIS) TO PREPARE FOR AN HIV COMMUNITY-BASED TRIAL IN VULINDLELA, SOUTH AFRICA (Project Accept-HPTN 043).

Authors:  Admire Chirowodza; Heidi van Rooyen; Philip Joseph; Sindisiwe Sikotoyi; Linda Richter; Thomas Coates
Journal:  J Community Psychol       Date:  2009

Review 6.  Generalizing Study Results: A Potential Outcomes Perspective.

Authors:  Catherine R Lesko; Ashley L Buchanan; Daniel Westreich; Jessie K Edwards; Michael G Hudgens; Stephen R Cole
Journal:  Epidemiology       Date:  2017-07       Impact factor: 4.822

7.  Financial Incentives for Linkage to Care and Viral Suppression Among HIV-Positive Patients: A Randomized Clinical Trial (HPTN 065).

Authors:  Wafaa M El-Sadr; Deborah Donnell; Geetha Beauchamp; H Irene Hall; Lucia V Torian; Barry Zingman; Garret Lum; Michael Kharfen; Richard Elion; Jason Leider; Fred M Gordin; Vanessa Elharrar; David Burns; Allison Zerbe; Theresa Gamble; Bernard Branson
Journal:  JAMA Intern Med       Date:  2017-08-01       Impact factor: 21.873

8.  Brief Report: Durability of the Effect of Financial Incentives on HIV Viral Load Suppression and Continuity in Care: HPTN 065 Study.

Authors:  Wafaa M El-Sadr; Geetha Beauchamp; H Irene Hall; Lucia V Torian; Barry S Zingman; Garret Lum; Richard A Elion; Kate Buchacz; David Burns; Allison Zerbe; Theresa Gamble; Deborah J Donnell
Journal:  J Acquir Immune Defic Syndr       Date:  2019-07-01       Impact factor: 3.731

9.  Effect of Universal Testing and Treatment on HIV Incidence - HPTN 071 (PopART).

Authors:  Richard J Hayes; Deborah Donnell; Sian Floyd; Nomtha Mandla; Justin Bwalya; Kalpana Sabapathy; Blia Yang; Mwelwa Phiri; Ab Schaap; Susan H Eshleman; Estelle Piwowar-Manning; Barry Kosloff; Anelet James; Timothy Skalland; Ethan Wilson; Lynda Emel; David Macleod; Rory Dunbar; Musonda Simwinga; Nozizwe Makola; Virginia Bond; Graeme Hoddinott; Ayana Moore; Sam Griffith; Nirupama Deshmane Sista; Sten H Vermund; Wafaa El-Sadr; David N Burns; James R Hargreaves; Katharina Hauck; Christophe Fraser; Kwame Shanaube; Peter Bock; Nulda Beyers; Helen Ayles; Sarah Fidler
Journal:  N Engl J Med       Date:  2019-07-18       Impact factor: 176.079

10.  HPTN 071 (PopART): rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment - a study protocol for a cluster randomised trial.

Authors:  Richard Hayes; Helen Ayles; Nulda Beyers; Kalpana Sabapathy; Sian Floyd; Kwame Shanaube; Peter Bock; Sam Griffith; Ayana Moore; Deborah Watson-Jones; Christophe Fraser; Sten H Vermund; Sarah Fidler
Journal:  Trials       Date:  2014-02-13       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.